SCIENCEYE BLOG

Contact

Healthspan

19 min read

Updated on October 8, 2026
A winding path through a painted landscape glowing gold for most of its length before it fades toward a dim sunset horizon showing healthspan within a lifespan

SHARE:

Introduction

Definition of Healthspan

Healthspan is the period of life spent in good health, free of serious chronic disease and disability. It complements lifespan, the total length of life, and at population level researchers usually measure it as health-adjusted, or healthy, life expectancy.1,2 Geroscience is the field that links the biology of aging to chronic disease. It treats longer healthspan as a central goal, because aging is the greatest risk factor for most chronic diseases.3

Context

The concept matters because longer lives are not always healthier ones. Across 183 World Health Organization member states, the gap between life expectancy and health-adjusted life expectancy widened over two decades to an average of 9.6 years.2 The definition itself remains contested, since researchers disagree on where good health ends and how best to measure it.4 The term now appears across biology, medicine, demography and philosophy. Healthspan also gives research a shared target. Rather than treat each disease of later life on its own, it asks how long the body as a whole stays healthy.3

Scope

This entry covers the definition of healthspan and its related measures. It then describes the biology and evolution of aging, how practitioners measure and extend healthspan, and the main controversies over its meaning and limits.

Healthspan within lifespan A bar representing lifespan from birth to death is divided into healthspan, the years in good health, and the healthspan-lifespan gap, the years lived in poor health at the end of life. Lifespan Healthspan Years in poor health Birth Death Healthspan-lifespan gap begins
Healthspan is the healthy portion of lifespan; the years after it form the healthspan-lifespan gap.2

Detailed Explanation

Components

Lifespan and life expectancy. Lifespan describes the length of an individual life, whereas life expectancy is a population average, usually calculated from birth. Record life expectancy is the highest national value in each year. It has risen by almost three months per year since 1840, and it has broken predicted ceilings on average five years after their publication.5 In high-income nations, life expectancy at birth rose by about 30 years over the twentieth century, largely through advances in public health and medicine.6 Mortality fell first at young ages and then at middle and older ages. Deaths now cluster in a narrower band of old age, a pattern called mortality compression.6 Fries had described the same shift in 1980. About 80% of the years lost to premature, nontraumatic death had been eliminated, and most premature deaths now came from the chronic diseases of later life. Survival curves were becoming more rectangular: more people reached old age and then died within a narrower range of ages.7

Healthy life expectancy. Healthy life expectancy (HALE) estimates the number of years a person can expect to live in full health. The Global Burden of Disease Study combines mortality data with years lived with disability to produce HALE for 204 countries and territories. Global HALE at birth rose from 61.3 years in 2010 to 62.2 years in 2021 (95% uncertainty interval 59.4 to 64.7). It fell by 2.2% (1.6 to 2.9) between 2019 and 2021, during the COVID-19 pandemic.8 The study draws on 100,983 data sources, including vital registration, censuses, household surveys and disease registries. It weights the prevalence of each condition by its severity to calculate years lived with disability, then combines these with age-specific death rates to estimate HALE.8 World Health Organization figures show global life expectancy at 73.3 years in 2023, nearly back to its 2019 level, while healthy life expectancy, at 62.8 years, had not fully recovered.9 Health expectancies differ in what they count as good health: some track years lived with disability, others years lived with disease.1

The healthspan-lifespan gap. The difference between life expectancy and health-adjusted life expectancy measures the years lived in poor health. Among 183 World Health Organization member states, this gap widened over two decades. Women showed a mean gap 2.4 years wider than men. The United States had the largest gap, at 12.4 years.2 Across world regions, life expectancy, national income and the burden of noncommunicable disease correlated most consistently with the size of the gap.10

MeasureWhat it countsExample source
LifespanLength of an individual lifeDong et al., 2016
Life expectancyAverage years of life in a population, usually from birthOeppen and Vaupel, 2002
Healthy life expectancy (HALE)Expected years in full health, from mortality and years lived with disabilityGBD 2021
Healthspan-lifespan gapLife expectancy minus health-adjusted life expectancyGarmany and Terzic, 2024
Biological ageAge of the body estimated from biomarkersLevine et al., 2018
Measures used to describe healthspan and lifespan.11,5,8,2,12

These measures matter because the leading causes of death have changed. Omran’s theory of the epidemiologic transition describes three stages. In the age of pestilence and famine, life expectancy ranged from 20 to 40 years. In the age of receding pandemics, it rose from about 30 to 50 years. In the age of degenerative and man-made diseases, it exceeded 50 years.13 In this last stage, fertility rather than mortality becomes the main driver of population growth.13 In the third stage, chronic diseases of later life dominate, so the quality of added years becomes as important as their number.

A simple example shows how these measures relate. If life expectancy in a country is 80 years and healthy life expectancy is 70 years, the healthspan-lifespan gap is 10 years. A longer life expectancy with the same healthy life expectancy widens the gap; a longer healthy life expectancy with the same life expectancy narrows it.

Variations

Compression of morbidity. In 1980, James Fries proposed the compression of morbidity. If medicine could postpone chronic illness while the maximum life span stayed fixed, illness would shrink into a short period near the end of life. He noted that average length of life had risen from 47 to 73 years during the twentieth century, while the maximum life span had not. He estimated an ideal average life span of about 85 years.7 He argued that health research should study how aging varies between people and how far people can modify it.7

Expansion of morbidity. The opposite scenario holds that treatment extends life for people who already have disease, so people live their added years with illness. Evidence from the United States fits this pattern in part. The age of onset of most health problems has changed little. Meanwhile, the prevalence of disease has risen markedly, largely because treatment extends life for those with disease. Some reductions in physical disability and dementia have nonetheless occurred.1 More people now reach old age and spend more years at older ages. The balance between healthy and unhealthy years therefore affects a growing share of the population.1

Definitions by setting. Population studies define healthspan through health expectancies, whereas clinical practice tracks it in individuals through frailty, disability and chronic disease.14 In laboratory mammals, genetic, dietary and pharmacological interventions can delay aging, which makes healthspan an experimental outcome as well as a population statistic.3 Lifespan in several animal species is flexible, and genetic or pharmaceutical intervention can increase it, a finding often cited against a fixed human limit.11 Biomarkers of biological age offer a further, individual-level definition.12

The distinction between lifespan and healthspan has sharpened as gains in life expectancy slow. Since 1990, gains in life expectancy have slowed in the longest-lived populations. Unless biological aging can be markedly slowed, survival to age 100 appears unlikely to exceed 15% for women and 5% for men this century.6 Life expectancy at birth is likewise unlikely to exceed 95 years without a fundamental change in the ability to delay aging.1

Healthspan describes how long people live in good health; lifespan and life expectancy describe only how long they live.

Scientific Basis

Biological Mechanisms

Aging is now described through a set of hallmarks, processes that change with age, accelerate aging when intensified and slow it when targeted. A 2023 synthesis listed twelve hallmarks. They are genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis.15 These hallmarks interact with each other and with proposed hallmarks of health, such as spatial compartmentalization, maintenance of homeostasis and adequate responses to stress.15 The hallmarks do not act alone; each connects to the others. Each hallmark must meet three conditions. It must appear with age. Intensifying it must speed aging. Treating it must slow, stop or reverse aging.15

Geroscience builds on this framework. Because aging is the largest single risk factor for most chronic diseases, slowing the underlying biology could delay several diseases at once rather than one at a time.3 The older population is growing quickly, which is why geroscience researchers call for more work aimed at extending human healthspan.3 Chronic inflammation, one of the hallmarks, links aging to conditions covered elsewhere in this wiki, including systemic inflammation and atherosclerosis.

From hallmarks of aging to loss of healthspan Twelve hallmarks of aging feed into a higher biological age, measured by biomarkers such as epigenetic clocks and vascular age, which leads to loss of healthspan through frailty and chronic disease. Hallmarks of aging Genomic instabilityTelomere attritionEpigenetic alterationsLoss of proteostasisDisabled macroautophagyDeregulated nutrient sensingMitochondrial dysfunctionCellular senescenceStem cell exhaustionAltered intercellular communicationChronic inflammationDysbiosis Biological age clocks, vascular age Loss of healthspan frailty, disease
The twelve hallmarks of aging raise biological age, which precedes the loss of healthspan.15,12

Evolutionary biology asks why aging exists at all. One early account proposed that mortality may reflect an energy-saving strategy in which the body invests less in correcting errors in somatic cells than in reproduction.16 This idea offered a new basis for studying both normal and abnormal aging.16 Data from hunter-gatherer populations suggest that a long post-reproductive life is itself an evolved human trait, with an estimated adaptive life span of 68 to 78 years. The study combined evidence on how dependency and food production change with age to explain why long life benefits the species.17 Evolutionary medicine adds the idea of evolutionary mismatch. Natural selection shaped human genes in environments that differ sharply from modern ones. That discordance promotes chronic diseases such as Atherosclerosis, hypertension, diabetes and obesity.18 On this view, people today are, genetically, Stone Age hunter-gatherers living in a changed world. Genes have changed little over the past 10,000 years, while culture has changed almost beyond recognition, especially since the Industrial Revolution. These diseases of civilization cause about 75% of deaths in Western nations but are rare among people whose ways of life resemble those of preagricultural ancestors.18 Researchers have even examined sitting, the most common modern behavior, for how far it departs from ancestral patterns.19 That work asked how ancestors sat, in what contexts, and how sitting interacts with Physical Activity and sleep across the 24-hour day.19

Evolutionary and biological accounts meet in one idea. Genes shaped for one environment now act in another, and the hallmarks of aging unfold against that background of mismatch.18,15

Evidence

Biomarkers of biological age provide the main evidence linking the biology of aging to healthspan. DNA methylation PhenoAge is an epigenetic clock built from clinical measures of phenotypic age. It predicts all-cause mortality, cancers, healthspan, physical functioning and Alzheimer’s disease. Faster epigenetic aging is associated with activation of pro-inflammatory pathways and reduced DNA damage response and mitochondrial activity.12 PhenoAge was built in two steps. Researchers first combined clinical measures into a phenotypic age, then found DNA methylation sites that tracked it. Although developed in whole blood, it correlates with age in every tissue and cell type tested.12 DNA methylation GrimAge combines seven methylation-based estimates of plasma proteins with an estimate of smoking pack-years. It predicts time to death, coronary heart disease and cancer. Its age-adjusted form is associated with the number of comorbid conditions, excess visceral fat and age at menopause.20 Researchers validated it in data from thousands of people, and it shows expected links with lifestyle factors, including healthy diet and educational attainment.20

Vascular measures offer a second line of evidence. Vascular age is an emerging health indicator and a predictor of damage to the heart, brain and kidney.21 Its authors called for reviews of long-term studies with repeated measures of vascular structure and function, because studies that measure people only once limit conclusions about timing.21 Carotid-femoral pulse wave velocity is the reference measure of aortic stiffness and an established marker of vascular aging. Researchers have tested a version estimated from age and blood pressure for studies that cannot measure it directly.22 The SciencEye post Pulse Wave Velocity: Physics to Clinical Prediction covers the principles behind the measure.

Current Understanding

Current evidence suggests that large further gains in healthspan depend on delaying aging itself. Compressing morbidity, or increasing the share of life spent healthy, would require delaying the physiological changes that lead to disease and disability.1 The same conclusion follows from mortality trends: unless biological aging can be markedly slowed, radical extension of human life is implausible this century.6 Increases in life expectancy at older ages are nonetheless likely to continue.1 Others read the steady rise in record life expectancy as evidence that no fixed ceiling has yet been reached.5 Healthspan research therefore centers on whether humans can safely modify the hallmarks of aging.3,15

Healthspan rests on the biology of aging: its hallmarks, its evolutionary origins and the biomarkers that estimate biological age.

Clinical and Practical Applications

Relevance

The global burden of ill health continues to grow in absolute terms. Disability-adjusted life-years count healthy life lost to illness and early death. Globally, they rose from 2.63 billion (95% uncertainty interval 2.44 to 2.85) in 2010 to 2.88 billion (2.64 to 3.15) in 2021, much of it from population growth and aging. Age-standardised rates fell by 14.2% (10.7 to 17.3) between 2010 and 2019, before rising during the pandemic. Noncommunicable diseases accounted for 1.73 billion of these years (1.54 to 1.94) in 2021, although their age-standardised rate fell by 6.4% (3.5 to 9.5) after 2010. In 2021 the leading causes were COVID-19, ischaemic heart disease, neonatal disorders and stroke. Among the 25 leading causes, rates rose most for anxiety disorders, depressive disorders and diabetes.8 Cardiovascular disease remains a leading cause of premature death and hospitalization, and it places heavy strain on health services and economies.23

The healthspan-lifespan gap has direct consequences for health systems. Across 183 countries, wider gaps were associated with a greater burden of noncommunicable diseases and total morbidity. The largest gap, in the United States, reflected a rise in noncommunicable diseases.2 A regional analysis found the gap in every World Health Organization region, with different sizes and disease patterns. Africa had the narrowest gap but the fastest expansion. Europe more often had gaps smaller than predicted. Projections to 2100 forecast continued widening in all regions.10 The analysis found three distinct clusters of disease burden and cautioned against global generalization, calling for solutions designed for each region.10 Within the 183-country analysis, countries with higher mortality tended to have narrower gaps.2 At the same time, lifespan inequality has declined as deaths concentrate at older ages.6

Measurement

In clinical practice, frailty often marks the end of healthspan. The Cardiovascular Health Study followed 5,317 adults aged 65 years and older. It defined frailty as three or more of five criteria: unintentional weight loss, self-reported exhaustion, weak grip strength, slow walking speed and low Physical Activity. Its prevalence was 6.9%, its four-year incidence 7.2%, and it independently predicted falls, worsening mobility or disability, hospitalization and death. Its authors offered the phenotype as a basis for clinical assessment and for designing future interventions. Frailty overlapped with, but differed from, comorbidity and disability.14 The study classed people meeting one or two criteria as intermediate; they had a higher risk of becoming frail within three to four years. Frailty was more common in women, rose with age, and was associated with lower education and income, poorer health and more chronic disease.14

Other measures capture earlier changes. Pulse wave velocity tracks vascular aging.22 Where studies cannot measure it directly, estimates from age and blood pressure offer a way to extend research on vascular aging.22 Epigenetic clocks estimate biological age from blood samples.12,20 These clocks indicate whether a person is aging faster or slower than chronological age suggests.12,20 At population level, healthy life expectancy remains the standard measure, published for every country by the Global Burden of Disease Study.8 Each measure answers a different question about healthspan. Healthy life expectancy describes populations. Frailty describes individuals near the end of healthspan.14 Biomarkers estimate the pace of aging earlier in life, before disease appears.12,22

StudyYearSampleMain finding
Fried et al.20015,317 adults aged 65+Frailty phenotype: prevalence 6.9%, predicts falls, disability and death
Garmany and Terzic2024183 WHO member statesHealthspan-lifespan gap widened to 9.6 years; largest in the United States
GBD 2021 Collaborators2024204 countries and territoriesGlobal HALE 62.2 years in 2021 (59.4 to 64.7)
Olshansky et al.2024Eight longest-lived countries, Hong Kong and the United StatesLife expectancy gains decelerated after 1990
Garmany and Terzic2025183 member states, six regionsGap present in all regions; projected to widen to 2100
Selected studies of healthspan and its measurement.14,2,8,6,10

Management

Because aging is the shared risk factor for most chronic diseases, interventions that slow aging could extend healthspan more than treating diseases one at a time.3 Physical Activity and cardiorespiratory fitness are among the best-supported routes to a longer healthspan. Decades of research associate both with lower mortality, longer life expectancy and better quality of life.23 Fries argued in 1980 that chronic illness could be postponed through changes in lifestyle, and that the physiological and psychological markers of aging can be modified. He held that raising the average age at first infirmity would make the curve of illness more rectangular, as the survival curve had become.7 In the United States, substantial gains in health and life expectancy could come from behavioral, lifestyle and policy changes that reduce socioeconomic disparities, without new scientific breakthroughs.1 Lifestyle factors such as nutrition, exercise and exposure to harmful substances interact with genetic processes to promote chronic disease.18 Public health agencies now advise less sedentary behavior, but current US guidance remains vague because mechanistic and clinical evidence is still limited.19 The SciencEye posts Physical Activity vs Antidepressants: The Surprising Results and Diabetes Control: A Scientific Showdown of Meds vs. Lifestyle discuss lifestyle approaches to specific conditions.

Frailty, vascular aging and biological age mark the end of healthspan in individuals; Physical Activity and fitness are among the best-supported ways to extend it.

Controversies and Limitations

Debates

Three debates surround healthspan. The first concerns definition: Kaeberlein has questioned the concept itself,4 and health expectancies differ in whether they count disability or disease.1 The second concerns limits. One analysis found that survival gains decline after age 100 and that the maximum age at death has not risen since the 1990s,11 whereas predicted ceilings on life expectancy have repeatedly been broken.5

The third concerns whether extending healthspan counts as natural aging. Philosophers judge naturalness by history, by properties or by relation to people, and each test gives a different answer.24 Some tests treat naturalness as all or nothing; others treat it as a matter of degree.24 One influential account defines health as normal, species-typical function,25 under which disease is any internal state that reduces function below the level typical for the species,25 while critics of the biomedical model argue that it leaves out the social, psychological and behavioral dimensions of illness.26 Engel proposed a biopsychosocial model in its place.26 The SciencEye post Is Healthspan the Same as Natural Aging? explores this question.

A further debate concerns equity. Women live longer than men but spend more years in poor health, with a gap 2.4 years wider on average.2 In the United States, health and life expectancy lag behind peer societies, and narrowing socioeconomic disparities could close much of that difference.1

DebateOne positionOpposing position
DefinitionHealthspan is measured by health expectanciesThe concept is poorly defined and inconsistently measured
Limits of lifespanMaximum human lifespan is fixedPredicted limits keep being broken
Natural agingHealthy aging means normal species-typical functionHealth also has social and psychological dimensions
Main debates about healthspan.4,11,5,25,26

Limitations

Healthspan estimates depend on how researchers define good health and on the quality of disability and disease data, which vary across countries.8 Most estimates of the healthspan-lifespan gap rely on modelled national data from the World Health Organization rather than on direct measurement in individuals.2 Studies that measure people only once cannot show whether vascular aging precedes or follows disease.21 Biomarkers of biological age predict outcomes but do not yet define healthspan on their own.12

References

  1. Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist. 2015;55(6):901-11. doi:10.1093/geront/gnv130
  2. Garmany A, Terzic A. Global healthspan-lifespan gaps among 183 World Health Organization member states. JAMA Netw Open. 2024;7(12):e2450241. doi:10.1001/jamanetworkopen.2024.50241
  3. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709-13. doi:10.1016/j.cell.2014.10.039
  4. Kaeberlein M. How healthy is the healthspan concept? GeroScience. 2018;40(4):361-4. doi:10.1007/s11357-018-0036-9
  5. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science. 2002;296(5570):1029-31. doi:10.1126/science.1069675
  6. Olshansky SJ, Willcox BJ, Demetrius L, Beltrán-Sánchez H. Implausibility of radical life extension in humans in the twenty-first century. Nat Aging. 2024;4(11):1635-42. doi:10.1038/s43587-024-00702-3
  7. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980;303(3):130-5. doi:10.1056/NEJM198007173030304
  8. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133-61. doi:10.1016/S0140-6736(24)00757-8
  9. World Health Organization. Life expectancy and healthy life expectancy. Global Health Observatory [Internet]. Geneva: WHO; [cited 2026 Oct 3]. who.int (Global Health Observatory)
  10. Garmany A, Terzic A. Healthspan-lifespan gap differs in magnitude and disease contribution across world regions. Commun Med (Lond). 2025;5(1):381. doi:10.1038/s43856-025-01111-2
  11. Dong X, Milholland B, Vijg J. Evidence for a limit to human lifespan. Nature. 2016;538(7624):257-9. doi:10.1038/nature19793
  12. Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-91. doi:10.18632/aging.101414
  13. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q. 2005;83(4):731-57. doi:10.1111/j.1468-0009.2005.00398.x
  14. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. doi:10.1093/gerona/56.3.m146
  15. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-78. doi:10.1016/j.cell.2022.11.001
  16. Kirkwood TB. Evolution of ageing. Nature. 1977;270(5635):301-4. doi:10.1038/270301a0
  17. Gurven M, Kaplan H. Longevity among hunter-gatherers: a cross-cultural examination. Popul Dev Rev. 2007;33(2):321-65. doi:10.1111/j.1728-4457.2007.00171.x
  18. Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84(4):739-49. doi:10.1016/0002-9343(88)90113-1
  19. Higgins S, Pomeroy A, Bates LC, Paterson C, Barone Gibbs B, Pontzer H, Stoner L. Sedentary behavior and cardiovascular disease risk: an evolutionary perspective. Front Physiol. 2022;13:962791. doi:10.3389/fphys.2022.962791
  20. Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303-27. doi:10.18632/aging.101684
  21. Kucharska-Newton AM, Stoner L, Meyer ML. Determinants of vascular age: an epidemiological perspective. Clin Chem. 2019;65(1):108-18. doi:10.1373/clinchem.2018.287623
  22. Heffernan KS, Stoner L, London AS, Augustine JA, Lefferts WK. Estimated pulse wave velocity as a measure of vascular aging. PLoS One. 2023;18(1):e0280896. doi:10.1371/journal.pone.0280896
  23. Faghy MA, Tatler A, Chidley C, Fryer S, Stoner L, Laddu D, et al. The physiologic benefits of optimizing cardiorespiratory fitness and Physical Activity: from the cell to systems level in a post-pandemic world. Prog Cardiovasc Dis. 2024;83:49-54. doi:10.1016/j.pcad.2024.02.006
  24. Siipi H. Dimensions of naturalness. Ethics Environ. 2008;13(1):71-103. muse.jhu.edu/article/253438
  25. Boorse C. Health as a theoretical concept. Philos Sci. 1977;44(4):542-73. cambridge.org (Philosophy of Science)
  26. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-36. doi:10.1126/science.847460

Related Entries

Related SciencEye entries Healthspan at the centre, linked to the wiki entries Atherosclerosis and Systemic Inflammation and to SciencEye blog posts on natural aging, pulse wave velocity, and lifestyle and chronic disease. HealthspanAtherosclerosisSystemic InflammationNatural aging (blog)Pulse wave velocity (blog)Lifestyle and disease (blog)
Healthspan and related SciencEye entries and posts.

External Resources

Leave a Reply

Your email address will not be published. Required fields are marked *